Interplay between the immune system and adipose tissue in obesity

MA Exley, L Hand, D O'Shea… - Journal of …, 2014 - joe.bioscientifica.com
Obesity is a major risk factor for metabolic disease, with white adipose tissue (WAT)
inflammation emerging as a key underlying pathology. Alongside its major role in energy …

Partners in crime: beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis

E Toren, KLS Burnette, RR Banerjee… - Frontiers in …, 2021 - frontiersin.org
Type 1 diabetes (T1D) is an autoimmune disease characterized by autoreactive T cell-
mediated destruction of insulin-producing pancreatic beta-cells. Loss of beta-cells leads to …

Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: a longitudinal cohort study

DH Sinn, D Kang, M Kang, E Guallar, YS Hong… - Hepatology, 2022 - journals.lww.com
Dedifferentiation‐associated inflammatory factors of long‐te... : Hepatology Dedifferentiation‐associated
inflammatory factors of long‐term expanded human hepatocytes exacerbate their elimination …

PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes

M Ben Nasr, S Tezza, F D'Addio, C Mameli… - Science translational …, 2017 - science.org
Immunologically based clinical trials performed thus far have failed to cure type 1 diabetes
(T1D), in part because these approaches were nonspecific. Because the disease is driven …

[HTML][HTML] Complement component C3 is highly expressed in human pancreatic islets and prevents β cell death via ATG16L1 interaction and autophagy regulation

BC King, K Kulak, U Krus, R Rosberg, E Golec… - Cell Metabolism, 2019 - cell.com
We show here that human pancreatic islets highly express C3, which is both secreted and
present in the cytosol. Within isolated human islets, C3 expression correlates with type 2 …

NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription

SJ Burke, D Lu, TE Sparer, T Masi… - American Journal …, 2014 - journals.physiology.org
Diabetes mellitus results from immune cell invasion into pancreatic islets of Langerhans,
eventually leading to selective destruction of the insulin-producing β-cells. How this process …

Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation

AMA Rokstad, I Lacik, P de Vos, BL Strand - Advanced drug delivery …, 2014 - Elsevier
Cell encapsulation has already shown its high potential and holds the promise for future cell
therapies to enter the clinics as a large scale treatment option for various types of diseases …

Role of the PD-1/PD-L1 dyad in the maintenance of pancreatic immune tolerance for prevention of type 1 diabetes

M Falcone, G Fousteri - Frontiers in endocrinology, 2020 - frontiersin.org
The human pancreas, like almost all organs in the human body, is immunologically tolerated
despite the presence of innate and adaptive immune cells that promptly mediate protective …

[HTML][HTML] Alginate encapsulant incorporating CXCL12 supports long-term allo-and xenoislet transplantation without systemic immune suppression

T Chen, J Yuan, S Duncanson, ML Hibert… - American Journal of …, 2015 - Elsevier
Islet transplantation represents a potentially curative approach for individuals with Type I
Diabetes. The requirement for systemic immune suppression to control immune-mediated …

CXCL2, a new critical factor and therapeutic target for cardiovascular diseases

LY Guo, F Yang, LJ Peng, YB Li… - Clinical and Experimental …, 2020 - Taylor & Francis
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Previous
studies have shown that inflammatory chemokines are involved in the physiological …